MPE Masterclass 2023 agenda

28 – 30 April 2023 – Dubrovnik, Croatia 

 

Friday, 28 April 2023
14:00 – 17:00 Participants’ check-in and registration
19:00 – 22:00 Welcome dinner at the hotel restaurant Lenga

Saturday, 29 April 2023

09:00 – 09:15 Welcome
Lise-lott Eriksson, President of MPE
 
09:15 – 10:30 Plenary session 1 – Myeloma and AL amyloidosis treatment updates
Prof. Dr. Moshe Gatt, Director, Hematology department, Hadassah Hebrew University Medical Center, Jerusalem
 
10:30 – 10:45 Coffee break  
10:45 – 11:45 Plenary session 2 – Health Technology Assessment (HTA)
Dr Neil Bertelsen, Steering Committee Member/Past Chair HTAi PCIG
MPE Member presentations
Emma Andersson, Association of Cancer Patients in Finland
Varda Shoham, AMEN, Israel
 
11:45 – 12:00 Coffee break  
12:00 – 13:00 Plenary session 3 – CAR-T
Dr Charlotte Pawlyn, PhD, Haematologist and Clinician Scientist, Cancer Research UK
 
13:00 – 13:05 Morning session close  
13:05 – 14:15 Lunch break  
14:15 – 15:15 Breakout session 1 – Improving access to clinical trials in Central and Eastern Europe (CEE)
Moderator:
Biljana Shrepfler (Biba), BORKA, Macedonia
Speakers:
Prof. Dr Roman Hajek, Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
Prof. Dr Oliver Karanfilski, University Clinic for Hematology, Skopje, Republic of North Macedonia
Dr Sandra Bašić Kinda, University Hospital Centre Zagreb, Croatia
Barbara Leonardi, MPE member, Carita, Poland
Breakout session 2 – Effective running of Facebook support groups
Zvika Zilberman, AMEN, Israel
15:15 – 16:00 Coffee break
Poster presentations
Member programmes, success stories and MPE projects
MPE members and MPE team
 
16:00 – 17:00 Breakout session 3 – Funding
Livija Rojc Štremfelj, Agencija LARS, Institution for culture, education and consulting, Cerkno, Slovenia
MPE Member presentation
Kristina Modic, L&L, Slovenia
Breakout session 4 – Press relations and media engagement
Marion Sauvebois, Myeloma UK
Ana Vallejo, MPE
MPE Member presentation
Łukasz Rokicki, Carita, Poland
17:00 – 17:05 Day one close
19:00 – 22:00 Offsite dinner


Sunday, 30 April 2023

09:00 – 09:10 Welcome
09:10 – 10:10 Plenary Session 4 – Importance of physical fitness for myeloma and AL amyloidosis patients and the impact on their Quality of Life (QoL)
Dr. Orla McCourt, University College London Hospitals NHS Foundation Trust, UK
MPE Member presentation
Milica Kuzmanoska, HEMA-ONKO, Macedonia
10:10 – 10:30 MPE presentation
MPE research and programmes / Launch of Clinical Trial Navigator
Silene Ten Seldam and Solene Clavreul, MPE
10:30 – 10:45 Coffee break
10:45 – 12:00 Panel Discussion – Future challenges in myeloma: Sequencing
Moderator:
Eric Low, Eric Low Consulting
Speakers:
Dr Charlotte Pawlyn, PhD, Haematologist and Clinician Scientist, Cancer Research UK
Prof. Dr. Roman Hajek, Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
Carole Longson, Independent Senior Adviser, Life Science Policy, HTA and Market Access
Tanja Podkonjak, Director of Access and Reimbursement Policy, Takeda EUCAN Oncology and Steering Committee member of EFPIA’s Oncology Platform
12:00 – 12:10 Informal Break
12:10 – 12:45 Movie screening – Documentary film about myeloma in Central and Eastern Europe (CEE)
L&L (Slovenia), Mijelom CRO (Croatia), HULL (Croatia), Udruzenje obolelih od multiplog mijeloma (Serbia)
12:45 – 13:00 Masterclass close
Lise-lott Eriksson, President of MPE
13:00 – 14:00 Farewell lunch